Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2013 by Retina Macula Institute.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Ron P. Gallemore, Retina Macula Institute Identifier:
First received: April 2, 2012
Last updated: January 13, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)